首页> 外文OA文献 >CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

【2h】

CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

机译：脂质体阿霉素与紫杉醇治疗艾滋病-Ks的CN3成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Raimundo K.; Asche C.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto-GBG 84): A randomised phase III trial [J] . Schneeweiss Andreas, Moebus Volker, Tesch Hans, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2019,第期

机译：激烈剂量 - 致密的Epirubicin，紫杉醇，环磷酰胺与每周紫杉醇，脂质体Doxorubicin（加上三重阴性乳腺癌中的Carboplatin）用于Neoadjuvant治疗高危早期乳腺癌（Geparocto-GBG 84）：随机期III试验
2. COMPARATIVE EFFECTIVENESS OF PLATINUM PLUS PACLITAXEL, PLATINUM PLUS LIPOSOMAL DOXORUBICIN, TOPOTECAN, AND LIPOSOMAL DOXORUBICIN FOR SECOND-LINE CHEMOTHERAPY AMONG PLATINUM-SENSITIVE PATIENTS WITH RECURRENT ADVANCED OVARIAN CANCER IN TAIWAN [J] . Huang H., Tang C., Cheng W., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：铂铂加紫杉醇，普至铂和台湾铂敏感患者二线化疗铂钙和脂质体多柔比星的比较效果
3. Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial. [J] . Pignata S, Scambia G, Ferrandina G, Journal of Clinical Oncology . 2011,第27期

机译：卡铂加紫杉醇与卡铂加聚乙二醇化脂质体阿霉素作为卵巢癌患者的一线治疗药物：MITO-2随机III期试验。
4. Acoustic Cluster Therapy displays theranostic capability in enhancing the effectiveness of liposomal doxorubicin treatment of human triple negative breast cancer in mice [C] . Nigel Bush, Andrew Healey, Anant Shah, IEEE International Ultrasonics Symposium . 2019

机译：声学聚类疗法在提高小鼠中提高人类三重阴性乳腺癌的脂质体Doxorubicin治疗的有效性方面的治疗能力
5. Cost effectiveness of liposomal doxorubicin versus paclitaxel for the treatment of advanced AIDS-related Kaposis Sarcoma. [D] . Raimundo, Karina Pupio. 2011

机译：脂质体阿霉素与紫杉醇在治疗晚期艾滋病相关的卡波西斯肉瘤中的成本效益。
6. Cost-effectiveness of paclitaxel doxorubicin cyclophosphamide and trastuzumab versus docetaxel cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china [O] . Qiaoping Xu, Li Yuanyuan, Zhu Jiejing, 2021

机译：紫杉醇多柔比蛋白环磷酰胺和曲妥珠单抗的成本效益与中国新佐剂治疗的多西紫杉醇顺铂和曲妥珠单抗
7. CN3 COMPARISON OFTHE COST-EFFECTIVENESS OF SIX CYCLES OFTAXOTERE, DOXORUBICIN, CYCLOPHOSPHAMIDE (TAC) VERSUS SIX CYCLES OF FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE (FAC) INTHE ADJUVANT SETTING OF NODE POSITIVE BREAST CANCERWITH PRIMARY AND SECONDARY G-CSF PROPHYLAXIS [O] . Mittmann N, Koo M, Alloul K, 2008

机译：CN3比较六环紫杉醇，阿霉素，环磷酰胺（TAC）相对于六环氟尿嘧啶，阿霉素，环磷酰胺（FAC）对结直肠癌的抗凝作用，以及对结点的多巴利多酚
8. Expanding the Adoption on Private Lands: Blowing-and-Drifting Snow Control Treatments and the Cost Effectiveness of Permanent versus Non-Permanent Treatment Options. [R] . Current, D., Wyatt, G., Zamora, D., 2017

机译：扩大对私人土地的采用：吹雪控制处理和永久性与非永久性治疗方案的成本效益。

CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

著录项

相似文献

相关主题

期刊订阅